Keywords: integrilin, approvable, usa, unstable, angina, cor, therapeutics

Integrilin "Approvable" In USA For Unstable Angina

Article | 08 April 1998

Print This

COR Therapeutics' stock shot up almost 80% last week after the US Foodand Drug Administration sent the company an "approvable" letter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in